Vernonia amygdalina ↔ antidiabetic activity

Relations (1)

related 2.32 — strongly supporting 4 facts

Vernonia amygdalina is a medicinal plant widely recognized for its therapeutic potential, specifically including its documented antidiabetic activity as evidenced by scientific studies [1] and general pharmacological claims [2], [3], and [4].

Facts (4)

Sources

Vernonia amygdalina: a comprehensive review of the ... frontiersin.org Frontiers 4 facts

claimIsolated compounds from Vernonia amygdalina have been reported to possess anti-inflammatory, antioxidant, antibacterial, antifungal, anti-cancer, anti-diabetic, and anti-helminthic activities in various studies.

claimVernonia amygdalina, commonly known as bitter leaf, is a medicinal plant traditionally used for therapeutic properties including antioxidant, antibacterial, anti-diabetic, anticancer, and anti-inflammatory effects to treat conditions ranging from infectious to digestive issues.

referenceIfedibaluChukwu E. I., Aparoop D., and Kamaruz Z. investigated the antidiabetic, anthelmintic, and antioxidation properties of phytocompounds isolated from the methanolic stem-bark of Vernonia amygdalina Delile (Asteraceae) in a 2020 study published in Scientific African.

claimResearchers have identified that Vernonia amygdalina contains bioactive molecules with potential anti-inflammatory, antioxidant, antibacterial, antifungal, anti-cancer, anti-diabetic, and anti-helminthic effects.